Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 759 | 880 | 295 | 685 | 1,183 |
| Gross Profit | 759 | 880 | 295 | 685 | 1,183 |
| Operating Expenses | 28,199 | 28,172 | 28,235 | 28,658 | 25,538 |
| Operating Income | -27,440 | -27,292 | -27,940 | -27,973 | -24,355 |
| Other Income | 3,423 | 3,509 | 3,161 | 1,838 | 617 |
| Pre-tax Income | -24,017 | -23,783 | -24,779 | -26,135 | -23,738 |
| Net Income Continuous | -24,017 | -23,783 | -24,779 | -26,135 | -23,738 |
| Net Income | $-24,017 | $-23,783 | $-24,779 | $-26,135 | $-23,738 |
| EPS Basic Total Ops | -0.39 | -0.38 | -0.41 | -0.46 | -0.51 |
| EPS Basic Continuous Ops | -0.39 | -0.38 | -0.41 | -0.46 | -0.51 |
| EPS Diluted Total Ops | -0.39 | -0.38 | -0.41 | -0.46 | -0.51 |
| EPS Diluted Continuous Ops | -0.39 | -0.38 | -0.41 | -0.46 | -0.51 |
| EBITDA(a) | $-26,909 | $-26,725 | $-27,374 | $-27,382 | $-23,744 |